Exercise for Enhancing COVID-19 Immunization
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines how a single session of light to moderate exercise, such as a brisk walk or jog, affects the immune response to the COVID-19 mRNA vaccine. Researchers aim to determine if exercising shortly after vaccination boosts the body's defenses, like antibodies and T cells, more than resting does. Participants will either exercise for 90 minutes after their shot or maintain their normal routine without exercise. This study suits individuals planning to receive the COVID-19 mRNA vaccine who already exercise regularly and can safely manage 90 minutes of light to moderate activity. As an unphased trial, it offers participants the chance to contribute to understanding how exercise might enhance vaccine effectiveness.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you are on medication that significantly impacts immune response, you may not be eligible to participate.
What prior data suggests that this exercise protocol is safe?
Research shows that most people can safely exercise soon after receiving a COVID-19 vaccine. Studies have found that light to moderate exercise, such as a brisk walk or jog for 90 minutes, poses no serious risks and can even increase antibody levels four weeks post-vaccination. This suggests exercise might enhance the body's response to the vaccine.
Additionally, recent COVID-19 vaccinations do not appear to affect how the body handles exercise, so getting a shot does not make exercising more dangerous. In fact, regular exercise might improve the immune system's response to the vaccine, especially in older individuals. Therefore, for those considering joining a trial involving exercise after vaccination, evidence suggests it is safe and could benefit the immune system.12345Why are researchers excited about this trial?
Researchers are excited about using exercise to enhance COVID-19 immunization because it offers a simple, non-invasive way to potentially boost vaccine effectiveness. Unlike standard treatments that focus solely on the vaccine itself, this approach investigates how a 90-minute session of light to moderate exercise post-vaccination could enhance the body's immune response. This method is particularly appealing because exercise is a natural, accessible activity with numerous other health benefits, and if successful, it could lead to improved vaccine outcomes without the need for additional medications.
What evidence suggests that exercise post-immunization could enhance the immune response to the COVID-19 vaccine?
Research shows that exercising after receiving a COVID-19 vaccine might enhance the body's response. In this trial, one group of participants will engage in a supervised 90-minute light to moderate exercise session after their initial mRNA-based COVID-19 vaccine. One study found that such exercise increased the number of antibodies (proteins that fight viruses) in the blood four weeks after the shot. Another study found that exercising soon after vaccination might improve the vaccine's effectiveness. This suggests that light to moderate exercise could help the immune system respond more effectively to the COVID-19 vaccine.12367
Are You a Good Fit for This Trial?
This trial is for adults aged 18-70 who are planning to get their initial or booster dose of a COVID-19 mRNA vaccine, exercise regularly, and can safely do 90 minutes of light to moderate exercise. It's not for pregnant individuals, those on immune-altering meds (for the initial vaccine part), or with conditions that make exercising unsafe.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Vaccination and Intervention
Participants receive the initial COVID-19 mRNA vaccine. Those in the exercise group perform a 90-minute light to moderate intensity exercise session within 30 minutes post-vaccination.
Short-term Follow-up
Participants are monitored for side effects and immune response. Blood samples are collected at 2 weeks and 1 month post-vaccination.
Long-term Follow-up
Participants are monitored for immune response with blood samples collected at 3, 6, and 12 months post-vaccination.
What Are the Treatments Tested in This Trial?
Interventions
- Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Iowa State University
Lead Sponsor